- Home
- TSHA vs GHM Comparison
TSHA vs GHM Comparison
Compare TSHA & GHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- GHM
- Stock Information
- Founded
- TSHA 2019
- GHM 1936
- Country
- TSHA United States
- GHM United States
- Employees
- TSHA N/A
- GHM N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- GHM Industrial Machinery/Components
- Sector
- TSHA Health Care
- GHM Industrials
- Exchange
- TSHA Nasdaq
- GHM Nasdaq
- Market Cap
- TSHA 403.7M
- GHM 471.2M
- IPO Year
- TSHA 2020
- GHM N/A
- Fundamental
- Price
- TSHA $2.00
- GHM $45.36
- Analyst Decision
- TSHA Strong Buy
- GHM Buy
- Analyst Count
- TSHA 8
- GHM 1
- Target Price
- TSHA $6.63
- GHM $35.00
- AVG Volume (30 Days)
- TSHA 5.4M
- GHM 68.3K
- Earning Date
- TSHA 11-13-2024
- GHM 02-03-2025
- Dividend Yield
- TSHA N/A
- GHM N/A
- EPS Growth
- TSHA N/A
- GHM 172.71
- EPS
- TSHA N/A
- GHM 0.71
- Revenue
- TSHA $9,915,000.00
- GHM $196,402,000.00
- Revenue This Year
- TSHA N/A
- GHM $13.21
- Revenue Next Year
- TSHA N/A
- GHM $9.89
- P/E Ratio
- TSHA N/A
- GHM $63.18
- Revenue Growth
- TSHA N/A
- GHM 11.88
- 52 Week Low
- TSHA $1.19
- GHM $17.99
- 52 Week High
- TSHA $4.32
- GHM $46.50
- Technical
- Relative Strength Index (RSI)
- TSHA 41.45
- GHM 67.87
- Support Level
- TSHA $1.97
- GHM $43.45
- Resistance Level
- TSHA $2.72
- GHM $46.50
- Average True Range (ATR)
- TSHA 0.23
- GHM 1.60
- MACD
- TSHA -0.10
- GHM -0.35
- Stochastic Oscillator
- TSHA 2.24
- GHM 67.29
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About GHM Graham Corporation
Graham Corporation designs and manufactures mission-critical fluid, power, heat transfer, and vacuum technologies for the defense, space, energy, and process industries. The company also services and sells spare parts for its equipment. It designs and manufactures custom-engineered vacuum, heat transfer, cryogenic pump and turbomachinery technologies.